All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

  TRANSLATE

The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The SOT Hub is an independent medical education platform, supported through a founding grant from Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Outcomes with controlled moderate hypothermic preservation vs static cold storage in heart transplantation

By Nathan Fisher

Share:

Apr 17, 2026

Learning objective: After reading this article, learners will be able to cite a new clinical development in heart transplantation.


Results from an analysis of the GUARDIAN-Heart Registry (NCT04141605), an international, multicenter, real-world registry evaluating controlled moderate hypothermic preservation using a cardiac transport system (CTS) vs conventional ice storage in adults undergoing heart transplantation, were published in The Journal of Heart and Lung Transplantation by Silvestry et al. The study compared post-transplant outcomes, including graft dysfunction and survival, between recipients of donor hearts preserved using the CTS (n = 695) and those preserved with conventional ice storage (n = 566).

Key data: Preservation using the CTS was identified as an independent predictor of reduced severe primary graft dysfunction (PGD; odds ratio [OR], 0.60; 95% confidence interval [CI], 0.40–0.89; p = 0.012) and right ventricular dysfunction (RVD; OR, 0.75; 95% CI, 0.57–1.00; p = 0.047). In propensity score-matched (PSM) analysis (n = 362 per group), use of the CTS was associated with lower rates of severe PGD (5.5% vs 11.0%; p = 0.008), severe RVD (5.5% vs 9.8%; p = 0.047), and post-transplant mechanical circulatory support (MCS; 19.1% vs 27.9%; p = 0.007) compared with ice storage. Two-year survival was higher with use of the CTS (94.3% vs 89.5%; p = 0.042), corresponding to a 47% reduced risk of death (hazard ratio [HR], 0.53; 95% CI, 0.30–0.92; p = 0.024). 

Key learning: Controlled moderate hypothermic heart preservation using a CTS was associated with improved post-transplant outcomes, including reduced graft dysfunction and higher 2‑year survival, compared with conventional ice storage. 

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content